Мировой рынок лечения грыжи межпозвоночного диска в поясничном отделе позвоночника – тенденции отрасли и прогноз до 2029 года

Анализ и размер рынка

Почти 80% населения хотя бы раз в жизни испытывают боль в пояснице (БП). БП обходится Соединенным Штатам более чем в 100 миллиардов долларов США в год из-за своей высокой распространенности и значительного вклада в инвалидность. Наиболее распространенной причиной БП является межпозвоночная дегенерация, которая приводит к дегенеративному заболеванию дисков и грыже поясничного диска (ГПМ). Грыжа поясничного диска, которая чаще всего поражает уровни L4-L5 и L5-S1, является основной причиной боли в пояснице и корешкового дискомфорта в ногах.

По данным Data Bridge Market Research, рынок лечения грыжи поясничного диска в 2021 году оценивался в 2,568 млн долларов США, а к 2029 году, как ожидается, достигнет 4,16 млн долларов США, что соответствует среднегодовому темпу роста в 6,20% в прогнозируемый период с 2022 по 2029 год. Отчет о рынке, подготовленный командой Data Bridge Market Research, включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ линейки продукции, анализ цен и нормативно-правовую базу.

Область отчета и сегментация рынка

Market Definition

Lumbar disc herniation (LDH) is a frequent low back condition. It's one of the most frequent disorders that causes low back and/or leg discomfort in people. A herniated disc occurs when disc material (nucleus pulposus or annulus fibrosis) is displaced outside the intervertebral disk's region. This herniation cycle begins with failure in the innermost annulus rings and moves radially outward. Damage to the annulus of the disc is commonly related with totally flexing the spine over an extended period of time.

Lumbar Disc Herniation Treatment Market Dynamics

Drivers

• High prevalence rate of smoking

The rise in prevalence rate of smoking will act as a major driver that will result in the expansion of the growth rate of the market. Smoking is thought to reduce the oxygen flow to discs, causing them to break down faster and hence will further cushion the growth rate of lumbar disc herniation treatment market.

• Sedentary lifestyle of people

The increasing prevalence of sedentary lifestyle among people such as lack of physical exercise is the major reason which is estimated to enhance the market’s growth rate during the forecast period of 2022-2029. Back problems are more common among people who work in physically demanding jobs. Lifting, pushing, twisting repeatedly, tugging, and bending laterally, can also lead to a herniated disc.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of lumbar disc herniation treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the lumbar disc herniation treatment market. Additionally, introduction and swift adoption related to the technologically advanced medical devices and surging geriatric population will result in the expansion of lumbar disc herniation treatment market.

 Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the lumbar disc herniation treatment market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the lumbar disc herniation treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and the dearth of skilled professionals will challenge the lumbar disc herniation treatment market. Additionally, strict food and drug administration (FDA) guidelines for approving new medication and lack of awareness about the treatment will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This lumbar disc herniation treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lumbar disc herniation treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Lumbar disc herniation treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Lumbar Disc Herniation Treatment Market

During the COVID-19 outbreak, the patient's condition in both the spinal outpatient and emergency departments has reached a critical stage, with a level of seriousness well above normal. Individuals have experienced anxiety disorders as a result of the COVID 19 pandemic, which was exacerbated by the epidemic's loneliness. Excessive concern about their health, illness, and contracting the coronavirus has resulted in an increase in hospital visits. To combat these difficulties, governments are investing in infrastructure connected to slipped disc issues, as well as the development of the COVID 19 vaccine and treatment.

Global Lumbar Disc Herniation Treatment Market Scope

The lumbar disc herniation treatment market is segmented on the basis of type, location type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Location Type

• Axillary
• Foraminal
• Posterolateral
• Central Prolapse

Diagnosis

• Nerve Tests
• Electromyography (EMG)
• Nerve conduction study
• Imaging Tests
• Magnetic resonance imaging (MRI)
• Myelogram
• Computerized tomography (CT) scan
• X-rays
• Others

Treatment

• Medication
• Non-steroidal anti-inflammatory drugs (NSAIDs)
• Opioids
• Muscle relaxers
• Local corticosteroid injections (CSI)
• Surgery
• Far lateral microdiskectomy
• Laminotomy and discectomy
• Physical Therapy
• Others

Type

• Chronic
• Acute

Dosage Form

• Injection
• Tablets
• Others

Route of Administration

• Parenteral
• Oral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Lumbar Disc Herniation Treatment Market Regional Analysis/Insights

The lumbar disc herniation treatment market is analysed and market size insights and trends are provided by country, type, location type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the lumbar disc herniation treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the lumbar disc herniation treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and rising healthcare expenditure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022-2029 due to surging prevalence of lumbar disc herniation in this region. Also, development of healthcare infrastructure and growing government initiatives will further propel the market’s growth rate in this region.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции и анализ пяти сил Портера, тематические исследования — вот некоторые из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговых путей.   

Анализ конкурентной среды и доли рынка лечения грыжи поясничного диска

Конкурентная среда рынка лечения грыжи поясничного диска содержит сведения по конкурентам. Включены сведения о компании, финансах компании, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта, доминировании в применении. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком лечения грыжи поясничного диска.

Некоторые из основных игроков, работающих на рынке лечения грыжи поясничного диска:

• Pfizer Inc. (США)
• GlaxoSmithKline plc (Великобритания)
• Новартис АГ (Швейцария)
• Mylan NV (США)
• Teva Pharmaceutical Industries Ltd. (Израиль)
• Санофи (Франция)
• Boehringer Ingelheim International GmbH. (Германия)
• АстраЗенека (Великобритания)
• Johnson & Johnson Private Limited (США)
• Merck & Co., Inc. (США)
• F. Hoffmann-La Roche Ltd. (Швейцария)
• Sun Pharmaceutical Industries Ltd. (Индия)
• Ауробиндо Фарма (Индия)
• Зидус Кадила (Индия)
• NuVasive, Inc. (США)
• Globus Medical (США)
• Zimmer Biomet (США)
• Medtronic (Ирландия)
• Страйкер (США)
• Assertio Therapeutics, Inc. (США) 

SKU-56397